Coty looks to buy Chanel’s Bourjois cosmetics brand
NEW YORK — Coty and Chanel announced that Coty has submitted a binding offer to acquire the Bourjois cosmetics brand from Chanel for 15 million Class A Coty shares. Chanel has agreed to enter into exclusive negotiations.
Bourjois’ portfolio of color cosmetic products are sold through approximately 23,000 points of sale in more than 50 countries around the world. Bourjois was founded in 1863, by French actor Joseph-Albert Ponsin, who developed a line of color cosmetics for his fellow actors.
"We are looking forward to having the Bourjois brand as part of our portfolio of leading beauty products, as well as welcoming Chanel as a Coty shareholder,” said Bart Becht, chairman and interim CEO of Coty Inc. “Bourjois’ brands are highly complementary to Coty’s existing color cosmetics portfolio. Additionally, the company’s strong heritage, quality image and leadership positions in a number of Western European countries where Coty is seeking to bolster its presence, provide a great opportunity for Coty to further strengthen its leadership position in the large and growing color cosmetics category.”
“We are excited about the potential opportunities that joining with Coty could present for Bourjois,” added Michael Rena, Chanel’s representative. “Coty and Bourjois share a passion for color cosmetics and together they would have strong potential to further advance their leadership in this attractive global category. We intend to examine the offer in more detail and enter constructive talks with Coty.”
The proposal is subject to customary closing conditions, including regulatory clearances.
Mission Pharmacal Company Introduces Two New Innovative Spray Products
Mission Pharmacal Company has developed two zinc-oxide sprays that are poised to set the environmental standard for aerosol performance – Dr. Smith’s® Diaper Rash Spray and Dr. Smith’s Rash+Skin® Spray. Mission Pharmacal used Honeywell Solstice® Propellant, one of the most environmentally preferable aerosol technologies available today, to bring to market these new products. The products offer touch-free application for ease and comfort when treating uncomfortable skin irritations such as diaper rash, incontinence-associated dermatitis and other skin irritations in babies, adults and seniors. The spray requires no rubbing in and sprays in place for effective treatment. With the introduction of the two spray products, Mission Pharmacal has expanded its trusted Dr. Smith’s® brand. Both are also available in an ointment. Dr. Smith’s® is a registered trademark of Mission Pharmacal Company.
Now in over 100,000 retail locations nationwide, blu eCigs has innovated the electronic cigarette industry in the United States. As an alternative to traditional cigarettes, blu e-cigarettes have no tobacco smoke, smell, or ash. The best-selling e-cigarette brand in the country, blu has distinguished itself by becoming THE standard by which both consumers and retailers measure product quality, innovation, and value.
blu is committed in driving consumers to retail stores. Consequently, a variety of retailers, from pharmacies to grocers to convenience stores, continue to show interest in carrying blu products. Retailers appreciate the exceptional customer service as well as the national marketing and advertising support they receive when they partner with blu.
Find out how blu can help you create an additional revenue stream. Contact your local Lorillard representative for more information.
NOT FOR SALE TO MINORS. ©2014 LOEC,Inc.
For more information contact Otis Peterson at 980-318-5960 or email email@example.com